Browse all articles >
TM4SF1 - A new immune target for treatment of hepatocellular carcinoma
Reply to “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma”
Comment on: Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma
Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma2023 October;29(4)
Systemic therapy in advanced hepatocellular carcinoma2023 April;29(2)